65,437 trials
Pediatric Crohn's Disease
Primary: Percentage of Participants With Adverse Events (AEs)/Adverse Drug Reactions (ADRs), Serious AEs/ADRs and Unexpected AEs/ADRs — 18.18; 14.69; 5.59; 3.50 percentage of…
Malignant Neoplasm of Female Breast
Primary: Overall Response Rate — 25; 21 Participants
Dry Eye
Primary: Sum of the Cooling Scale For Rohto (r) Hydra — 24.6; 12.1 units on a scale
Thymoma
Primary: Percent of Patients With Objective Response — 7.1 percentage of participants
Carcinoma, Hepatocellular
Primary: Time to Progression-Blinded Independent Central Review (BICR) Assessment — 5.6; 4.1 Months — p=0.7382
Pre Eclampsia
Primary: Accuracy of Blood Pressure Readings by Sphygmo — 114.5; 115.6; 65.7; 66.3 mmHg
Infections, Bacterial
Primary: Area Under the Plasma Concentration-time Curve From Time Zero (Pre-dose) to Last Time of Quantifiable Concentration Within a Participant Across All Treatments (AUC[0-t])…
Head and Neck Squamous Cell Carcinoma · Recurrent Head and Neck Carcinoma
Primary: Overall Response Rate — 1; 0; 2; 3 Participants — p=0.99
Smoking Cessation
Primary: Number of Participants Reporting Smoking Abstinence — 30 Participants
Osteoporosis
Primary: Bone Mineral Density (BMD) — -3.97; 14.30; -27.3; -9.58 Percent change
Anesthesia
Primary: Mean Time to Pulpal Response After Maxillary Molar Anesthesia — 98.8; 84.5 minutes
Acute Myeloid Leukemia · Untreated Adult Acute Myeloid Leukemia
Primary: Event-free Survival (EFS) — 0.36; 0.41; 0.37 Proportion of participants — p=0.84
Herpes Zoster
Primary: Frequencies of Glycoprotein E (gE)-Specific Cluster of Differentiation 4 (CD4) / CD8 T Cells With at Least Two Antigen-specific Cytokines: Interferon Gamma (IFN-γ)…
Excision of Kidney
Primary: Proportion of Vessels Transected Requiring Intra-Operative Hemostatic Interventions — 0.1359; 0.1836 proportion of transected vessels
Stress, Psychological · Inflammation · Cortisol
Primary: Change in Interleukin-6 (IL-6) — .05; .16; .31; .24 log(picograms/mL)